Great to see more news, palatability of the drug should not be an issue at this next phase but from the next one so there is still time for the capsules to be produced. I am extremely positive on this company but I would caution that there is no garuntee that there will be a greater reduction in the cancer marker on the next dosage it may just be the same level of reduction. However a consistent finding all the way through in the reduction of certain cancer markers should be enough to see a significant change in PAA's fortunes.
Great to see more news, palatability of the drug should not be...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 152309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 329859 | 3 |
View Market Depth
| Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |